Search Within

Nursing

  1. "Sujata Patil"
Formats
  1. Meeting Abstract (41)
  2. Journal Article (19)
Groups
  1. Biostatistics Service (60)
  2. Epidemiology and Biostatistics (60)
  3. Department of Medicine (50)
  4. Solid Tumor Oncology Division (50)
  5. Survivorship Research (50)
  6. Surgery (37)

More Groups

People
  1. Sujata Patil (60)
  2. Darren Feldman (20)
  3. Robert Motzer (20)
  4. Clifford Hudis (18)
  5. George Bosl (15)
  6. Edi Brogi (14)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (2)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer Research (10)
  3. Annals of Surgical Oncology (7)
  4. Cancer (3)
  5. Journal of the American Geriatrics Society (2)
  6. Annals of Surgery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. American Association for Cancer Research (11)
  3. Springer (8)
  4. Wiley Blackwell (5)
  5. Elsevier Inc. (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors
    Journal Article

    Funt, S. A.; McHugh, D. J.; Tsai, S.; Knezevic, A.; O'Donnell, D.; Patil, S.; Silber, D.; Bromberg, M.; Carousso, M.; Reuter, V. E.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A pilot study of radiation (RT) and CTLA4-mediated checkpoint blockade with tremelimumab for the treatment of breast cancer brain metastases (BCBM)
    Meeting Abstract

    McArthur, H. L.; Beal, K.; Halpenny, D.; Henrich, M.; Patil, S.; Young, R.; Kaley, T.; Hamilton, N.; Hudis, C.; Wolchok, J.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling
    Journal Article

    McArthur, H. L.; Diab, A.; Page, D. B.; Yuan, J.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Durack, J. C.; Maybody, M.; Sung, J.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin efficacy for first-line treatment of patients with intermediate- or poor-risk germ cell tumors
    Journal Article

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Lim, K.; Patil, S.; Woo, K. M.; Carousso, M.; Hughes, A.; Sheinfeld, J.; Bains, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; Haque, S.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Fertility preservation for the young breast cancer patient
    Journal Article

    Goldfarb, S. B.; Kamer, S. A.; Oppong, B. A.; Eaton, A.; Patil, S.; Junqueira, M. J.; Olcese, C.; Kelvin, J. F.; Gemignani, M. L.
    Annals of Surgical Oncology (2016)

    Fulltext@MSK | Save